Integra Lifesciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Integra Lifesciences using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-30 | $0.54 | $0.43 | 25.6 % |
| Q2 | 2025-07-31 | $0.45 | $0.43 | 4.65 % |
| Q1 | 2025-05-05 | $0.41 | $0.43 | -4.65 % |
| Q4 | 2025-02-25 | $0.97 | $0.86 | 12.8 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-30 | $402.06M | $414.50M | -3.00 % |
| Q2 | 2025-07-31 | $415.61M | $395.29M | 5.14 % |
| Q1 | 2025-05-05 | $382.65M | $381.17M | 0.39 % |
| Q4 | 2025-02-25 | $442.65M | $445.15M | -0.56 % |
Integra Lifesciences (IART) is scheduled to report earnings on February 24, 2026. The last reported earnings were for reported on October 30, 2025 for Q3.
The Actual EPS was $0.54, which beat the estimate of $0.43.
The Actual Revenue was $402.1M, which missed the estimate of $414.5M.
Browse earnings estimates, EPS, and revenue on all stocks.